{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:54:38Z","timestamp":1784289278073,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702265"],"award-info":[{"award-number":["81702265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009156","name":"Nantong Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022SX00000446"],"award-info":[{"award-number":["2022SX00000446"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["ZM202017"],"award-info":[{"award-number":["ZM202017"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["ZD2022027"],"award-info":[{"award-number":["ZD2022027"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.canlet.2023.216426","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:27:26Z","timestamp":1696832846000},"page":"216426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["ITPR1-AS1 promotes small cell lung cancer metastasis by facilitating P21 splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade"],"prefix":"10.1016","volume":"577","author":[{"given":"Quanli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2755-413X","authenticated-orcid":false,"given":"Jiawen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9467-2964","authenticated-orcid":false,"given":"Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-4251","authenticated-orcid":false,"given":"Rong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10299","key":"10.1016\/j.canlet.2023.216426_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-019-0736-3","article-title":"Emerging therapies for small cell lung cancer","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2023.216426_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/cbin.11359","article-title":"New insights into small-cell lung cancer development and therapy","volume":"44","author":"Wang","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"9804","key":"10.1016\/j.canlet.2023.216426_bib4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2023.216426_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41568-021-00353-1","article-title":"Long noncoding RNAs in cancer metastasis","volume":"21","author":"Liu","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","article-title":"Revealing protein-lncRNA interaction","volume":"17","author":"Ferre","year":"2016","journal-title":"Briefings Bioinf."},{"issue":"6","key":"10.1016\/j.canlet.2023.216426_bib9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib10","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/nar\/gky095","article-title":"Splicing regulation by long noncoding RNAs","volume":"46","author":"Romero-Barrios","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib11","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1038\/s41467-021-24099-4","article-title":"The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis","volume":"12","author":"Teng","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.canlet.2023.216426_bib12","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41418-018-0242-0","article-title":"A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer","volume":"26","author":"Ding","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2023.216426_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.canlet.2023.216426_bib14","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","article-title":"MEK inhibitors for the treatment of non-small cell lung cancer","volume":"14","author":"Han","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.molcel.2016.10.029","article-title":"Inhibition of ras\/Raf\/MEK\/ERK pathway signaling by a stress-induced phospho-regulatory circuit","volume":"64","author":"Ritt","year":"2016","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.canlet.2023.216426_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10555-020-09920-8","article-title":"Splice variants of RAS-translational significance","volume":"39","author":"Raso","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.canlet.2023.216426_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1209117","article-title":"Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling","volume":"25","author":"Khanzada","year":"2006","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.canlet.2023.216426_bib21","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/onc.2014.190","article-title":"DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway","volume":"34","author":"Chen","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-021-01325-7","article-title":"DDX3X: structure, physiologic functions and cancer","volume":"20","author":"Mo","year":"2021","journal-title":"Mol. Cancer"},{"issue":"29","key":"10.1016\/j.canlet.2023.216426_bib23","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/onc.2011.515","article-title":"PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling","volume":"31","author":"Shrestha","year":"2012","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050382","article-title":"RAC1 takes the lead in solid tumors","volume":"8","author":"De","year":"2019","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.canlet.2023.216426_bib25","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1074\/jbc.M210318200","article-title":"Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition","volume":"278","author":"Tran","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.canlet.2023.216426_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cac2.12155","article-title":"Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6\/E2F1 positive feedback loop in lung adenocarcinoma","volume":"41","author":"Zhang","year":"2021","journal-title":"Cancer Commun. (Lond)"},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bbrc.2017.06.180","article-title":"ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma","volume":"490","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","article-title":"Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2023.216426_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.omtn.2020.11.012","article-title":"circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression","volume":"23","author":"Liang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK pathway in KRAS-driven tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.canlet.2023.216426_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110458","article-title":"Aberrant RNA splicing in cancer and drug resistance","volume":"10","author":"Wang","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.canlet.2023.216426_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0092-8674(89)90427-3","article-title":"Expression of the H-ras proto-oncogene is controlled by alternative splicing","volume":"58","author":"Cohen","year":"1989","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2023.216426_bib35","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1128\/MCB.23.8.2927-2941.2003","article-title":"Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation","volume":"23","author":"Guil","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2023.216426_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002926","article-title":"P68 RNA helicase (DDX5) alters activity of cis- and trans-acting factors of the alternative splicing of H-Ras","volume":"3","author":"Camats","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib37","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41598-018-20360-x","article-title":"hnRNP A1\/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage","volume":"8","author":"Cloutier","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.canlet.2023.216426_bib38","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.7150\/thno.51360","article-title":"SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.canlet.2023.216426_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5877","article-title":"RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2023.216426_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106140","article-title":"TRIM58 inactivates p53\/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer","volume":"143","author":"Wang","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.canlet.2023.216426_bib41","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/bioinformatics\/btx742","article-title":"3dRPC: a web server for 3D RNA-protein structure prediction","volume":"34","author":"Huang","year":"2018","journal-title":"Bioinformatics"},{"issue":"23","key":"10.1016\/j.canlet.2023.216426_bib42","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1038\/onc.2010.95","article-title":"Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.canlet.2023.216426_bib43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrc.2017.87","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.canlet.2023.216426_bib44","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1101\/gad.263145.115","article-title":"Origins, genetic landscape, and emerging therapies of small cell lung cancer","volume":"29","author":"Semenova","year":"2015","journal-title":"Genes Dev."},{"issue":"Pt 2","key":"10.1016\/j.canlet.2023.216426_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semcancer.2022.05.004","article-title":"Small cell lung cancer: novel treatments beyond immunotherapy","volume":"86","author":"Meijer","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.canlet.2023.216426_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"issue":"22","key":"10.1016\/j.canlet.2023.216426_bib47","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","article-title":"Noncoding RNAs regulate alternative splicing in Cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrg2776","article-title":"Alternative splicing and evolution: diversification, exon definition and function","volume":"11","author":"Keren","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2016.01.029","article-title":"Widespread expansion of protein interaction capabilities by alternative splicing","volume":"164","author":"Yang","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2023.216426_bib51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","article-title":"Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors","volume":"5","author":"Frampton","year":"2015","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.canlet.2023.216426_bib52","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","article-title":"The functional impact of alternative splicing in cancer","volume":"20","author":"Climente-Gonzalez","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2023.216426_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100728","article-title":"The role of alternative splicing in cancer: from oncogenesis to drug resistance","volume":"53","author":"Sciarrillo","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"7629","key":"10.1016\/j.canlet.2023.216426_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature20149","article-title":"Local regulation of gene expression by lncRNA promoters, transcription and splicing","volume":"539","author":"Engreitz","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/15476286.2022.2062846","article-title":"Mechanisms of non-coding RNA-modulated alternative splicing in cancer","volume":"19","author":"Wang","year":"2022","journal-title":"RNA Biol."},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib56","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/nar\/gkz1237","article-title":"Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4\/U6 recycling factor SART3","volume":"48","author":"De Troyer","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.canlet.2023.216426_bib57","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1530\/ERC-11-0041","article-title":"The RNA-binding protein Sam68 is a multifunctional player in human cancer","volume":"18","author":"Bielli","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2023.216426_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010281","article-title":"DDX3X multifunctionally modulates tumor progression and serves as a prognostic indicator to predict cancer outcomes","volume":"21","author":"Lin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216426_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12943-015-0461-7","article-title":"DDX3, a potential target for cancer treatment","volume":"14","author":"Bol","year":"2015","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2023.216426_bib60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.15252\/emmm.201404368","article-title":"Targeting DDX3 with a small molecule inhibitor for lung cancer therapy","volume":"7","author":"Bol","year":"2015","journal-title":"EMBO Mol. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:12:28Z","timestamp":1759594348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523003774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"alternative-id":["S0304383523003774"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216426","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ITPR1-AS1 promotes small cell lung cancer metastasis by facilitating P21HRAS splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216426"}}